Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochim Biophys Acta. 2009 Sep;1792(9):874-80. doi: 10.1016/j.bbadis.2008.12.010. Epub 2009 Jan 9.

Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG.

Author information

1
Departamento de Hematologia, CIPM, Instituto Portugês de Oncologia Francisco Gentil, Lisbon, Portugal.

Abstract

Tethering to cell membrane through attachment to the complex glycolipid anchor glycosylphosphatidyl inositol (GPI) is a mode of protein expression highly conserved in eukaryotes. The evolutionary purpose of such an elaborate way of expressing proteins is not clear and neither is the functional role of GPI itself. GPI-anchored proteins (GPI-AP) serve a variety of functions that include adhesion, receptors, signal transduction and complement activation. GPI biosynthesis, a process that is accomplished in at least 9 steps and involves several proteins, some with enzymatic activity, would be expected to be a fertile ground for development of inherited, autosomal recessive disorders. However, until recently, paroxysmal nocturnal haemoglobinuria, a rare haematological disorder caused by somatic mutations in the X-linked PIGA gene, was the only genetic disorder affecting GPI biosynthesis. Here we review the clinical spectrum, biochemical defect and genetic pathogenesis of inherited GPI deficiency, the first described form of inherited, autosomal recessive disorder of GPI biosynthesis and outline the molecular basis of targeted therapy for this condition.

PMID:
19168132
DOI:
10.1016/j.bbadis.2008.12.010
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center